Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125

Gynecologic Oncology

Volumn 62, Issue 3, 1996, Pages 384-389

  Zeimet, Alain G ^a   Marth, Christian ^a   Offner, Felix A ^b   Obrist, Peter ^b   Uhl Steidl, Michael ^a   Feichtinger, Hans ^b   Stadlmann, Sylvia ^b   Daxenbichler, Günter ^a   Dapunt, Otto ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OVARY CANCER; PERITONEUM CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030245748     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0253     Document Type: Article

References (31)

1. 1. Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., and Knapp, R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma, J. Clin. Invest. 68, 1331-1337 (1981).
2. 2. Davis, H., Zurawski, V., Bast, R., and Klug, T. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas, Cancer Res. 46, 6143-6148 (1986).
3. 3. Fuith, L. C., Daxenbichler, G., and Dapunt, O. CA-125 in the serum and tissue of patients with gynecological disease, Arch. Gynecol. Obstet. 241, 157-164 (1987).
4. 4. Berchuck, A., Soisson, A. P., Clarke-Pearson, D. L., Soper, J. T., Boyer, C. M., Kinney, R. B., McCarty, K. S., and Bast, R. C. Immunohistochemical expression of CA-125 in endometrial adenocarcinoma: Correlation of antigen expression with metastatic potential, Cancer Res. 49, 2091-2095 (1989).
5. 5. Kabawat, S. E., Bast, R. C., Welch, W. R., Knapp, R. C., and Colvin, R. B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types, Am. J. Clin. Pathol. 79, 98-104 (1983).
6. 6. Barbieri, R. L., Niloff, J. M., Bast, R. C., Schaetzl, E., Kistner, R. W., and Knapp, R. C. Elevated serum concentrations of CA-125 in patients with advanced endometriosis, Fertil. Steril. 45, 630-634 (1986).
7. 7. Zeimet, A. G., Müller-Holzner, E., Marth, C., Daxenbichler, G., and Dapunt, O. Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle, Fertil. Steril. 59, 1028-1035 (1993).
8. 8. Fuith, L. C., Müller-Holzner, E., Marth, C., Zeimet, A. G., Perkmann, E., and Daxenbichler, G. Distribution of CA 125 in placental tissues, Int. J. Biol. Markers 4, 78-80 (1989).
9. 9. Bast, R. C., Klug, T. L., St. John, E., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., Zurawski, V. R., and Knapp, R. C. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, New Engl. J. Med. 309, 883-887 (1983).
10. 10. Duk, J. M., Aalders, J. G., Fleuren, G. J., and de Bruijn, H. W. A. CA-125: A useful marker in endometrial carcinoma, Am. J. Obstet. Gynecol. 155, 1097-1102 (1986).
11. 11. Jacobs, I., and Bast, R. C. The CA-125 tumor associated antigen: A review of the literature, Hum. Reprod. 4, 1-12 (1989).
12. 12. Kenemans, P., Yedema, C. A., Bon, G. G., and von Mensdorff-Pouilly, S. CA 125 in gynecological pathology: A review, Eur. J. Obstet. Gynecol. Reprod. Biol. 49, 115-124 (1993).
13. 13. Halilah, H., Stenman, U., and Seppala, M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy, Cancer 57, 1327-1329 (1986).
14. 14. Di-Xia, C., Schwartz, P., Xinguo, L., and Zhan, Y. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses, Obstet. Gynecol. 72, 23-27 (1988).
15. 15. Bergmann, J., Beaugrand, M., Labadie, H., Bidart, J., and Bohuon, C. CA 125 (ovarian tumor-associated antigen) in ascitic liver diseases, Clin. Chim. Acta 155, 163-166 (1986).
16. 16. Redman, C. W. E., Jones, S. R., Luesly, D. M., Nicholl, S. E., Kelly, K., Buxton, E. J., Chan, K. K., and Blackledge, G. R. P. Peritoneal trauma releases CA 125? Br. J. Cancer 58, 502-504 (1988).
17. 17. Bergmann, J., Bidart, J., Geroge, M., Blaugrand, M., Levy, V. G., and Bohuon, C. Elevation of CA-125 in patients with benign and malignant ascites, Cancer 59, 213-217 (1987).
18. 18. Metzger, J., Haussinger, K., Wilmanns, W., and Lamerz, R. Hohe CA 125-Serumspiegel bei benignem Aszites oder Pleuraerguss, Geburtshilfe Frauenheilkd 47, 463-465 (1987).
19. 19. Kabawat, S. E., Bast, R. C., Bhan, A. K., Welch, W. R., Knapp, R. C., and Colvin, R. B. Tissue distribution of a coelomic epithelium related antigen recognized by the monoclonal antibody OC-125, Int. J. Gynecol. Pathol. 2, 275-285 (1984).
20. 20. Hunter, V. J., Weinberg, J. B., Haney, A. F., Soper, J. T., Lavin, P., Metsch, L., Knapp, R. C., and Bast, R. C. CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer, Gynecol. Oncol. 36, 161-165 (1990).
21. 21. Offner, F. A., Wirtz, H. C., Schiefer, J., Bigalke, I., Klosterhalfen, B., Bittinger, F., Mittermayer, C., and Kirkpatrick, C. J. Interaction of human malignant melanoma (ST-ML-12) tumor steroids with endothelial cell monolayers: Damage to endothelium by oxygen-derived free radicals, Am. J. Pathol. 141, 601-610 (1992).
22. 22. Wu, Y. J., Parker, L. M., Binder, N. E., Beckett, M. A., Sinard, J. H., Griffiths, C. T., and Rheinwald, J. G. The mesothelial keratins: A new familiy of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia, Cell 31, 693-703 (1982).
23. 23. Offner, F. A., Ott, G., Povey, S., Knuechel, R., Preisler, V., Fuezesi, L., Klosterhalfen, B., Ruebben, H., Hofstaedter, F., and Kirkpatrick, C. J. Characterization of the new bladder cell line HOK-1: Expression of transitional squamous and glandular differentiation patterns, Int. J. Cancer 49, 122-128 (1991).
24. 24. Buller, R. E., Menetta, A., Bloss, J., DiSaia, P. J., and Berman, M. L. Does intraperitoneal CA-125 reflect disease status? Gynecol. Oncol. 40, 66-69 (1991).
25. 25. Berek, J. S., Knapp, R. C., Malkasian, G. C., Lavin, P. T., Whitney, C., Niloff, J. M., and Bast, R. C. CA-125 levels correlated with second look operations among ovarian cancer patients, Obstet. Gynecol. 67, 685-689 (1986).
26. 26. Brand, E., and Lidor, Y. The decline of CA 125 level after surgery reflects the size of residual ovarian cancer, Obstet. Gynecol. 81, 29-32 (1993).
27. 27. Zeillemaker, A. M., Verbrugh, H. A., Hoynck van Papendrecht, A. A. G. M., and Leguit, P. CA 125 secretion by peritoneal mesothelial cells, J. Clin. Pathol. 47, 263-265 (1994).
28. 28. Van Niekerk, C. C., Jap, P. H. K., Thomas, C. M. G., Smeets, D. F. C. M., Ramaekers, F. C. S., and Poels, L. G. Marker profile of mesothelial cells versus ovarian carcinoma cells, Int. J. Cancer 43, 1065-1071 (1989).
29. 29. Marth, C., Zeimet, A. G., Böck, G., and Daxenbichler, G. Modulation of tumour marker CA-125 expression in cultured ovarian carcinoma cells, Eur. J. Cancer 28A, 2002-2006 (1992).
30. 30. Marth, C., Fuith, L. C., Böck, G., Daxenbichler, G., and Dapunt, O. Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon, Cancer Res. 49, 6538-6542 (1989).
31. 31. Scambia, G., Panici, P. B., Baiocchi, G., Gallo, A., Laurelli, G., Iacobelli, S., and Mancuso, S. Recombinant alpha-2b-interferon dynamic test as a potential tool in predicting disease status during second look in ovarian cancer, Cancer 68, 2582-2585 (1991).